2-(2,4-Difluorophenoxy)-5-fluoroaniline
|
- $205 - $802.73
- Product name: 2-(2,4-Difluorophenoxy)-5-fluoroaniline
- CAS: 152666-72-3
- MF: C12H8F3NO
- MW: 239.19
- EINECS:
- MDL Number:MFCD08687554
- Synonyms:Benzenamine, 2-(2,4-difluorophenoxy)-5-fluoro-;2-(2,4-Difluorophenoxy)-5-fluoroaniline
4 prices
Selected condition：
Brand
- American Custom Chemicals Corporation
- Crysdot
- Matrix Scientific
Package
- 500.00mg
- 500MG
- 5g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0042252
- Product description2-(2,4-DIFLUOROPHENOXY)-5-FLUOROANILINE 95.00%
- Packaging500MG
- Price$802.73
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12138894
- Product description2-(2,4-Difluorophenoxy)-5-fluoroaniline 97%
- Packaging5g
- Price$648
- Updated2026-05-27
- Buy
- ManufacturerMatrix Scientific
- Product number022331
- Product description2-(2,4-Difluorophenoxy)-5-fluoroaniline
- Packaging500mg
- Price$205
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number022331
- Product description2-(2,4-Difluorophenoxy)-5-fluoroaniline
- Packaging500.00mg
- Price$205
- Updated2026-05-18
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| American Custom Chemicals Corporation | HCH0042252 | 2-(2,4-DIFLUOROPHENOXY)-5-FLUOROANILINE 95.00% | 500MG | $802.73 | 2021-12-16 | Buy |
| Crysdot | CD12138894 | 2-(2,4-Difluorophenoxy)-5-fluoroaniline 97% | 5g | $648 | 2026-05-27 | Buy |
| Matrix Scientific | 022331 | 2-(2,4-Difluorophenoxy)-5-fluoroaniline | 500mg | $205 | 2021-12-16 | Buy |
| Matrix Scientific | 022331 | 2-(2,4-Difluorophenoxy)-5-fluoroaniline | 500.00mg | $205 | 2026-05-18 | Buy |
Properties
Boiling point :264.6±40.0 °C(Predicted)
Density :1.367±0.06 g/cm3(Predicted)
pka :2.75±0.10(Predicted)
Density :1.367±0.06 g/cm3(Predicted)
pka :2.75±0.10(Predicted)
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|